The UCSF School of Pharmacy’s Small Molecule Discovery Center (SMDC) provided a key assist to researchers seeking to repurpose existing drugs to treat the worldwide scourge of amoebic dysentery.
In the June, 2012 issue of Nature Medicine (and online in advance on Nature’s web site), researchers from seven labs including the...
Health policy expert Lisa Bero, PhD, is hailed in the latest issue of The Lancet for tackling hot-button subjects such as financial biases in drug research.
The profile titled “taking the path of most resistance,” is both online and in the respected global medical journal’s May 19, 2012 print issue. It...
Studies of cancer drug dosing in children, possible medication links to delirium in hospital patients, and how to decide when swallowed batteries may call for invasive removal took top honors at the Department of Clinical Pharmacy’s 14th annual Spring Research Seminar.
The poster session, covering a total of 71 projects, highlighted...
On March 22 and 23, 2012, the U.S. Food and Drug Administration (FDA) held a public hearing to explore the idea of switching some medications to treat chronic conditions and health emergencies from prescription to over- and behind-the-counter status. Representing a group of academic health professionals, called The Self Care Collaborative,...
Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy, was honored by the UCSF Medical Center on May 4, 2012 for her “exceptional vision as a leader, commitment to patients, compassion as a human being, and dedication to UCSF Medical Center and UCSF Benioff Children’s Hospital.”
The leadership award is...
Harry W. Hind, a 1939 graduate of the UCSF School of Pharmacy who invented solutions that revolutionized contact lens use, as well as a topical patch to treat pain from shingles, died on April 12 at age 96.
Hind co-founded Barnes-Hind Pharmaceuticals Inc., which developed drugs to treat tuberculosis and glaucoma. He was...
Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF bioengineer Shuvo Roy, PhD, as a prime example of biomedical collaboration with potentially major...
From the start of his illustrious half-century career in mass spectrometry, Al Burlingame, PhD, has been part of a scientific sea change.
In his first lab at UC Berkeley, complete with a dirt floor and leaky roof, he looked for signs of extraterrestrial life in meteorites. He compares an earlier mass spectrometry...
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:
Malaria treatment for HIV-positive children and pregnant women Francesca Aweeka, PharmD Professor in residence Awarded $579,350...